Cargando…
Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas
Epidermal growth factor receptor (EGFR) inhibitors have been widely used for the treatment of epithelial malignancies. A wide spectrum of skin toxicities have been described in patients receiving EGFR inhibitors. Trichomegaly, especially of the eyelashes is a rare side effect of this therapy. We rep...
Autores principales: | Goel, Varun, Raina, Shubhra, Chandragouda, D, Singh, Sajjan, Talwar, Vineet, Patnaik, Nivedita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124690/ https://www.ncbi.nlm.nih.gov/pubmed/25114450 http://dx.doi.org/10.4103/0974-7753.136755 |
Ejemplares similares
-
Erlotinib Induced Trichomegaly of the Eyelashes
por: Jeon, Sang-Hoon, et al.
Publicado: (2013) -
Eyelash Trichomegaly
por: Kaur, Sandeep, et al.
Publicado: (2015) -
Essential Trichomegaly of the Eyelashes
por: Fernández-Crehuet, Pablo, et al.
Publicado: (2016) -
Eyelashes Trichomegaly: An Unusual Side Effect of Gefitinib Therapy
por: Agrawal, Chaturbhuj R, et al.
Publicado: (2018) -
Epidermal growth factor receptor inhibitors related trichomegaly of Eyelashes
por: Maka, Vinayak V., et al.
Publicado: (2014)